China Insurance Investment Co., Ltd.
Overview
China Insurance Investment Co., Ltd. is an investment institution established with the approval of the State Council of China, which focuses on investments in infrastructure, public services, and emerging industries in line with national policies. It also serves as the general partner for the China Insurance Investment Fund.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Infinigence AI | Oct 2026 | Series C | Co-investor |
| Emposat | Jun 2026 | Series D | Co-investor |
| AlphaPai | Sep 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Insurance Investment Co., Ltd. based?
China Insurance Investment Co., Ltd. is headquartered in Shanghai, China.
When was China Insurance Investment Co., Ltd. founded?
China Insurance Investment Co., Ltd. was founded in 2015.
How many portfolio companies does China Insurance Investment Co., Ltd. have?
China Insurance Investment Co., Ltd. has 4 portfolio companies in Caplight's dataset.
What are some companies in China Insurance Investment Co., Ltd.'s portfolio?
Portfolio companies visible on Caplight include Infinigence AI, Emposat, AlphaPai.
What was China Insurance Investment Co., Ltd.'s most recent investment shown here?
China Insurance Investment Co., Ltd.'s most recent investment in this portfolio sample was in Infinigence AI in 2026.
What sectors does China Insurance Investment Co., Ltd. focus on?
China Insurance Investment Co., Ltd. focuses on Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, FinTech, Telecommunications & Networking, Frontier & Industrial Tech, Enterprise Software, Enterprise Software.
What company stages does China Insurance Investment Co., Ltd. focus on?
Stage focus information for China Insurance Investment Co., Ltd. is not publicly available.
What is China Insurance Investment Co., Ltd.'s AUM?
China Insurance Investment Co., Ltd.'s assets under management are estimated between $54.8B and $62.5B.